The restructuring events database contains factsheets with data on large-scale restructuring events reported in the principal national media and company websites in each EU Member State. This database was created in 2002.
Manufacturing Manufacture Of Chemicals And Pharamceuticals Manufacture Of Basic Pharmaceutical Products And Pharmaceutical Preparations 21 - Manufacture of basic pharmaceutical products and pharmaceutical preparations
200 jobs Number of planned job losses
Announcement Date
16 November 2012
Employment effect (start)
1 December 2012
Foreseen end date
31 December 2012
Description
On 8 November 2012, the pharmaceutical company MSD announced plans to cut 200 jobs by the end of 2012. The dismissals will affect approximately half of MSD’s workforce.
Similar to other pharmaceutical companies in Poland, MSD implements redundancies due to the crisis that has affected the pharmaceutical market. According to IMS Health nearly 3,000 pharmaceutical jobs will have been lost in Poland by the end of the year, amongst fears that this figure will increase in 2013.
Sources
28 November 2012: Puls Biznesu ()
16 November 2012: Stowarzyszenie Marketingu Bezpośredniego ()
Citation
Eurofound (2012), MSD, Internal restructuring in Poland, factsheet number 74681, European Restructuring Monitor. Dublin, https://restructuringeventsprod.azurewebsites.net/restructuring-events/detail/74681.
Digitisation and automation technologies, including artificial intelligence (AI), can affect working conditions in a variety of ways and their use in the workplace raises a host of new ethical concerns.
The retail banking sector is fertile ground for studying the impacts of digitalisation on work and employment. Financial services are increasingly provided online, without the intermediary of customer-facing institutions.
European labour markets have recovered strongly from COVID-19. By the end of 2021, little more than 18 months after the start of the pandemic, employment rates in the EU were almost at pre-crisis levels.
